Olli is a physician-scientist working as a postdoctoral fellow at the Wellcome Sanger Institute. His research focuses on deciphering the genomic determinants of anti-cancer immunity using organoid models, single-cell genomics and genetic engineering. Olli completed his medical degree and his PhD at the University of Helsinki in Finland, where he studied immune interactions and precision medicine in blood cancers.